225 related articles for article (PubMed ID: 38324572)
1. Modulation of α-synuclein in vitro aggregation kinetics by its alternative splice isoforms.
Röntgen A; Toprakcioglu Z; Tomkins JE; Vendruscolo M
Proc Natl Acad Sci U S A; 2024 Feb; 121(7):e2313465121. PubMed ID: 38324572
[TBL] [Abstract][Full Text] [Related]
2. 14-3-3 Proteins Reduce Cell-to-Cell Transfer and Propagation of Pathogenic α-Synuclein.
Wang B; Underwood R; Kamath A; Britain C; McFerrin MB; McLean PJ; Volpicelli-Daley LA; Whitaker RH; Placzek WJ; Becker K; Ma J; Yacoubian TA
J Neurosci; 2018 Sep; 38(38):8211-8232. PubMed ID: 30093536
[TBL] [Abstract][Full Text] [Related]
3. α-Synuclein Strains and Their Relevance to Parkinson's Disease, Multiple System Atrophy, and Dementia with Lewy Bodies.
Graves NJ; Gambin Y; Sierecki E
Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569510
[TBL] [Abstract][Full Text] [Related]
4. α-Synuclein Radiotracer Development and In Vivo Imaging: Recent Advancements and New Perspectives.
Alzghool OM; van Dongen G; van de Giessen E; Schoonmade L; Beaino W
Mov Disord; 2022 May; 37(5):936-948. PubMed ID: 35289424
[TBL] [Abstract][Full Text] [Related]
5. Phosphatidylinositol-3,4,5-trisphosphate interacts with alpha-synuclein and initiates its aggregation and formation of Parkinson's disease-related fibril polymorphism.
Choong CJ; Aguirre C; Kakuda K; Beck G; Nakanishi H; Kimura Y; Shimma S; Nabekura K; Hideshima M; Doi J; Yamaguchi K; Nakajima K; Wadayama T; Hayakawa H; Baba K; Ogawa K; Takeuchi T; Badawy SMM; Murayama S; Nagano S; Goto Y; Miyanoiri Y; Nagai Y; Mochizuki H; Ikenaka K
Acta Neuropathol; 2023 May; 145(5):573-595. PubMed ID: 36939875
[TBL] [Abstract][Full Text] [Related]
6. Isomers of human alpha-synuclein stabilized by disulfide bonds exhibit distinct structural and aggregative properties.
Jiang C; Chang JY
Biochemistry; 2007 Jan; 46(2):602-9. PubMed ID: 17209570
[TBL] [Abstract][Full Text] [Related]
7. α-Synuclein conformers reveal link to clinical heterogeneity of α-synucleinopathies.
Schmitz M; Candelise N; Canaslan S; Altmeppen HC; Matschke J; Glatzel M; Younas N; Zafar S; Hermann P; Zerr I
Transl Neurodegener; 2023 Mar; 12(1):12. PubMed ID: 36915212
[TBL] [Abstract][Full Text] [Related]
8. Non-SUMOylated alternative spliced isoforms of alpha-synuclein are more aggregation-prone and toxic.
Hassanzadeh K; Morrone C; Akhtari K; Gerhardt E; Zaccagnini L; Outeiro TF; Feligioni M
Mech Ageing Dev; 2023 Jan; 209():111759. PubMed ID: 36464085
[TBL] [Abstract][Full Text] [Related]
9. Differential aggregation properties of alpha-synuclein isoforms.
Bungeroth M; Appenzeller S; Regulin A; Völker W; Lorenzen I; Grötzinger J; Pendziwiat M; Kuhlenbäumer G
Neurobiol Aging; 2014 Aug; 35(8):1913-9. PubMed ID: 24629672
[TBL] [Abstract][Full Text] [Related]
10. The structural differences between patient-derived α-synuclein strains dictate characteristics of Parkinson's disease, multiple system atrophy and dementia with Lewy bodies.
Van der Perren A; Gelders G; Fenyi A; Bousset L; Brito F; Peelaerts W; Van den Haute C; Gentleman S; Melki R; Baekelandt V
Acta Neuropathol; 2020 Jun; 139(6):977-1000. PubMed ID: 32356200
[TBL] [Abstract][Full Text] [Related]
11. Synucleinopathies Take Their Toll: Are TLRs a Way to Go?
Mazzotta GM; Ceccato N; Conte C
Cells; 2023 Apr; 12(9):. PubMed ID: 37174631
[TBL] [Abstract][Full Text] [Related]
12. A precipitating role for truncated alpha-synuclein and the proteasome in alpha-synuclein aggregation: implications for pathogenesis of Parkinson disease.
Liu CW; Giasson BI; Lewis KA; Lee VM; Demartino GN; Thomas PJ
J Biol Chem; 2005 Jun; 280(24):22670-8. PubMed ID: 15840579
[TBL] [Abstract][Full Text] [Related]
13. Alpha-synuclein-induced mitochondrial dysfunction is mediated via a sirtuin 3-dependent pathway.
Park JH; Burgess JD; Faroqi AH; DeMeo NN; Fiesel FC; Springer W; Delenclos M; McLean PJ
Mol Neurodegener; 2020 Jan; 15(1):5. PubMed ID: 31931835
[TBL] [Abstract][Full Text] [Related]
14. Lysophagy protects against propagation of α-synuclein aggregation through ruptured lysosomal vesicles.
Kakuda K; Ikenaka K; Kuma A; Doi J; Aguirre C; Wang N; Ajiki T; Choong CJ; Kimura Y; Badawy SMM; Shima T; Nakamura S; Baba K; Nagano S; Nagai Y; Yoshimori T; Mochizuki H
Proc Natl Acad Sci U S A; 2024 Jan; 121(1):e2312306120. PubMed ID: 38147546
[TBL] [Abstract][Full Text] [Related]
15. Cellular α-synuclein pathology is associated with bioenergetic dysfunction in Parkinson's iPSC-derived dopamine neurons.
Zambon F; Cherubini M; Fernandes HJR; Lang C; Ryan BJ; Volpato V; Bengoa-Vergniory N; Vingill S; Attar M; Booth HDE; Haenseler W; Vowles J; Bowden R; Webber C; Cowley SA; Wade-Martins R
Hum Mol Genet; 2019 Jun; 28(12):2001-2013. PubMed ID: 30753527
[TBL] [Abstract][Full Text] [Related]
16. α-Synuclein Seeding Assay Using RT-QuIC.
Okuzumi A; Hatano T; Fukuhara T; Ueno S; Nukina N; Imai Y; Hattori N
Methods Mol Biol; 2021; 2322():3-16. PubMed ID: 34043187
[TBL] [Abstract][Full Text] [Related]
17. Human myeloperoxidase (hMPO) is expressed in neurons in the substantia nigra in Parkinson's disease and in the hMPO-α-synuclein-A53T mouse model, correlating with increased nitration and aggregation of α-synuclein and exacerbation of motor impairment.
Maki RA; Holzer M; Motamedchaboki K; Malle E; Masliah E; Marsche G; Reynolds WF
Free Radic Biol Med; 2019 Sep; 141():115-140. PubMed ID: 31175983
[TBL] [Abstract][Full Text] [Related]
18. RT-QuIC Using C-Terminally Truncated α-Synuclein Forms Detects Differences in Seeding Propensity of Different Brain Regions from Synucleinopathies.
Poggiolini I; Erskine D; Vaikath NN; Ponraj J; Mansour S; Morris CM; El-Agnaf OMA
Biomolecules; 2021 May; 11(6):. PubMed ID: 34072869
[TBL] [Abstract][Full Text] [Related]
19. New insights into cellular α-synuclein homeostasis in health and disease.
Dettmer U; Selkoe D; Bartels T
Curr Opin Neurobiol; 2016 Feb; 36():15-22. PubMed ID: 26282834
[TBL] [Abstract][Full Text] [Related]
20. An α-synuclein decoy peptide prevents cytotoxic α-synuclein aggregation caused by fatty acid binding protein 3.
Fukui N; Yamamoto H; Miyabe M; Aoyama Y; Hongo K; Mizobata T; Kawahata I; Yabuki Y; Shinoda Y; Fukunaga K; Kawata Y
J Biol Chem; 2021; 296():100663. PubMed ID: 33862084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
